The Scope E-Newsletter June 2009

The Scope: June 2009

From the Dean's Office

Welcome Board of Visitors

Bright Spots

Share a Bright Spot

Beasley Recognized for 50 Years

Wallace Named Fulbright Scholar

In the Spotlight

Goldman Honored for Dedication

Gray First in Tennessee

Family Medicine Adds AOA Accreditation

Urology Earns Accreditation

Sim Man Receives New Aorta

FBI Trains with Marks

Physicians Provide TMA Leadership

Physicians Receive FLS Certification

Burgiss Serves on TME Editorial Board

Cox Named TSA President-Elect

Dougherty Hoods Dr. Licata

Neff Retires after 17-Year Tenure

Preston Measures CAPHIS Success

Radiology Updates Residents' Lounge

Waters Inducted to AAGUS

New Faculty and Staff

News

Headshots to be taken July 1

Fellows' Research Workshop July 6-10

Sick Leave Bank Open Enrollment

Continuing Medical and Dental Education

CMDE Calendar

Heart, Lung, Vascular Conference Reaches Primary Care Providers

Stroke Symposium Presents Guidelines, Emergent Treatments

Sullivan CDE Lecture Discusses Growth Factor and Technology Use

Research

Graduate School of Medicine Shares Knowledge Worldwide

   Research Highlights

   Presentations

   Publications

 

Read all articles in this issue of The Scope

Print

Gray First in Tennessee

Keith Gray, MD
Keith Gray, MD

Keith D. Gray, MD, Assistant Professor, Surgery, recently performed open hepatic microwave ablation, the first such procedure in Tennessee. Microwave (MW) ablation, a relatively new hepatic ablation technique in the U.S., uses probe-directed microwave energy to ablate tumors. Compared to radiofrequency ablation, this technique offers the advantage of ablating tumors at higher temperatures (up to 150 C), killing tumors situated close to blood vessels, and ablating larger tumors.

Dr. Gray emphasizes that MW ablation does not replace surgical resection but can be used as an adjunct to surgery and with patients who are not good surgical candidates. Since his inaugural procedure, Dr. Gray has found hepatic microwave ablation to be a suitable option for other patients with a variety of the different malignant tumor types.

Similarly, J. Mark McKinney, MD, Chair, Interventional Radiology, recently was the first in the state to perform percutaneous hepatic microwave ablation. Overall, MW ablation expands the options available for patients with primary and metastatic liver tumors. Dr. Gray expects that the technique will find increasing appeal in the ablation of other solid organ tumors.

Print

Submit News to GSM